Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.10 +0.24 (+0.83%)
As of: Oct 2, 2026 · 12:24 PM EDT

Lakefront Biotherapeutics (LKFT) Other Non-Current Liabilities (2013 - 2026)

Updated

Lakefront Biotherapeutics' Other Non-Current Liabilities came in at $16.14 million for the quarter ended Mar 31, 2026, down 43.3% from $28.48 million a year earlier but up 10.0% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Other Non-Current Liabilities was $14.24 million, down 61.1% from the prior year.

  • Other Non-Current Liabilities carries a five-year compound annual growth rate of -72.6% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Other Non-Current Liabilities was $36.61 million in the year ended Dec 31, 2024 (+7.8%), $33.97 million in the year ended Dec 31, 2023 (-99.9%), $22.98 billion in the year ended Dec 31, 2022 (+172.2%) and $8.44 billion in the year ended Dec 31, 2021 (-8.7%).
  • The five-year range for quarterly Other Non-Current Liabilities is $7.8 million (the quarter ended Jun 30, 2021) to $22.25 billion (the quarter ended Dec 31, 2022).
  • Year-over-year, Other Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 25.5% over the last six quarters.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in the quarter ended Dec 31, 2022 (growth of 172.6%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 99.8%).
  • Business Quant data shows LKFT's Other Non-Current Liabilities at $14.67 million (quarter ended Dec 31, 2025), $28.3 million (quarter ended Sep 30, 2025) and $24.43 million (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lakefront Biotherapeutics 1.95 Bn 1.95 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 16.14 Mn
Dec 31, 2025 14.67 Mn
Sep 30, 2025 28.30 Mn
Jun 30, 2025 24.43 Mn
Mar 31, 2025 28.48 Mn
Dec 31, 2024 36.14 Mn
Sep 30, 2024 33.94 Mn
Mar 31, 2024 46.59 Mn
Dec 31, 2023 33.97 Mn
Sep 30, 2023 34.24 Mn
Mar 31, 2023 25.24 Mn
Dec 31, 2022 22.25 Bn
Mar 31, 2022 10.75 Mn
Dec 31, 2021 8.16 Bn
Jun 30, 2021 7.80 Mn
Dec 31, 2020 9.65 Bn
Jun 30, 2020 11.78 Mn
Mar 31, 2020 8.96 Mn
Dec 31, 2019 7.74 Mn
Sep 30, 2019 2.75 Mn
API Access

Lakefront Biotherapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LKFT&period=max&api_key=YOUR_API_KEY